Dashboard
Company has a low Debt to Equity ratio (avg) at 0 times
Healthy long term growth as Operating profit has grown by an annual rate 61.09%
Flat results in Mar 26
Stock is technically in a Mildly Bullish range
With ROE of 6.4, it has a Very Expensive valuation with a 3 Price to Book Value
Increasing Participation by Institutional Investors
Market Beating Performance
Stock DNA
Other Chemical products
INR 2,234 Cr (Micro Cap)
50.00
42
0.00%
-0.26
10.17%
3.21
Total Returns (Price + Dividend) 
Stallion India for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Stallion India Fluorochemicals Ltd Technical Momentum Shifts to Mildly Bullish
Stallion India Fluorochemicals Ltd has shifted its technical momentum from a sideways trend to a mildly bullish stance, reflecting a nuanced change in market sentiment. Despite a slight dip in the stock price, key indicators such as MACD and Bollinger Bands on the weekly chart signal potential upside, while daily moving averages suggest caution. This mixed technical landscape warrants a closer examination for investors seeking clarity on the stock’s near-term trajectory.
Read More
Stallion India Fluorochemicals Ltd Valuation Shifts Signal Elevated Price Risk
Stallion India Fluorochemicals Ltd has witnessed a significant re-rating in its valuation parameters, moving from an expensive to a very expensive territory. Despite a robust 16.33% surge in its share price on 20 May 2026, the micro-cap chemical company’s elevated price-to-earnings and price-to-book ratios raise questions about its price attractiveness relative to historical and peer benchmarks.
Read More
Stallion India Fluorochemicals Ltd is Rated Sell
Stallion India Fluorochemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read More Announcements 
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
05-Jun-2026 | Source : BSEThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Neomile Corporate Advisory Ltd & Neomile Growth Fund Series I
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
03-Jun-2026 | Source : BSEResult of Postal Ballot
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
22-May-2026 | Source : BSETranscript of the Investor Conference for the business and financial performance of the Company for the Quarter & Financial Year ended on 31st March 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Stallion India Fluorochemicals Ltd has announced 19:41 rights issue, ex-date: 11 Feb 26
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 15 FIIs (1.78%)
Shazad Sheriar Rustomji (47.77%)
Neomile Corporate Advisory Limited (7.16%)
30.0%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 5.10% vs -0.86% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -1.80% vs -2.54% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 53.51% vs 51.75% in Sep 2024
Growth in half year ended Sep 2025 is 31.44% vs 204.60% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 41.97% vs 11.42% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 24.90% vs 60.97% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 14.10% vs 61.83% in Mar 2025
YoY Growth in year ended Mar 2026 is 35.60% vs 108.99% in Mar 2025